UBS AM’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-13,911
| Closed | -$147K | – | 2656 |
|
2023
Q2 | $147K | Hold |
13,911
| – | – | ﹤0.01% | 2606 |
|
2023
Q1 | $147K | Buy |
13,911
+2,766
| +25% | +$29.2K | ﹤0.01% | 2606 |
|
2022
Q4 | $378K | Hold |
11,145
| – | – | ﹤0.01% | 2281 |
|
2022
Q3 | $535K | Sell |
11,145
-1,848
| -14% | -$88.7K | ﹤0.01% | 2322 |
|
2022
Q2 | $741K | Sell |
12,993
-7,272
| -36% | -$415K | ﹤0.01% | 2118 |
|
2022
Q1 | $1.64M | Buy |
20,265
+2,828
| +16% | +$229K | ﹤0.01% | 1892 |
|
2021
Q4 | $3.53M | Buy |
17,437
+116
| +0.7% | +$23.5K | ﹤0.01% | 1571 |
|
2021
Q3 | $4.67M | Hold |
17,321
| – | – | ﹤0.01% | 1378 |
|
2021
Q2 | $4.46M | Buy |
17,321
+482
| +3% | +$124K | ﹤0.01% | 1428 |
|
2021
Q1 | $5.05M | Sell |
16,839
-101
| -0.6% | -$30.3K | ﹤0.01% | 1328 |
|
2020
Q4 | $4.32M | Buy |
16,940
+2,349
| +16% | +$599K | ﹤0.01% | 1360 |
|
2020
Q3 | $3.63M | Buy |
14,591
+314
| +2% | +$78.1K | ﹤0.01% | 1287 |
|
2020
Q2 | $4.96M | Sell |
14,277
-2,151
| -13% | -$747K | ﹤0.01% | 1120 |
|
2020
Q1 | $4.4M | Buy |
16,428
+1,219
| +8% | +$326K | ﹤0.01% | 1086 |
|
2019
Q4 | $4.92M | Sell |
15,209
-16,141
| -51% | -$5.23M | ﹤0.01% | 1195 |
|
2019
Q3 | $8.57M | Sell |
31,350
-13,287
| -30% | -$3.63M | 0.01% | 1005 |
|
2019
Q2 | $23.8M | Sell |
44,637
-4,579
| -9% | -$2.44M | 0.02% | 719 |
|
2019
Q1 | $24.8M | Buy |
49,216
+401
| +0.8% | +$202K | 0.02% | 691 |
|
2018
Q4 | $24.1M | Buy |
48,815
+5,542
| +13% | +$2.73M | 0.02% | 660 |
|
2018
Q3 | $39.6M | Buy |
43,273
+4,046
| +10% | +$3.7M | 0.03% | 570 |
|
2018
Q2 | $28.7M | Buy |
39,227
+24,005
| +158% | +$17.6M | 0.02% | 677 |
|
2018
Q1 | $24.3M | Buy |
15,222
+496
| +3% | +$791K | 0.02% | 719 |
|
2017
Q4 | $13.2M | Sell |
14,726
-12,804
| -47% | -$11.5M | 0.01% | 846 |
|
2017
Q3 | $9.91M | Buy |
27,530
+6,869
| +33% | +$2.47M | 0.01% | 902 |
|
2017
Q2 | $6.06M | Buy |
20,661
+14,051
| +213% | +$4.12M | 0.01% | 994 |
|
2017
Q1 | $2.33M | Buy |
6,610
+286
| +5% | +$101K | ﹤0.01% | 1285 |
|
2016
Q4 | $1.16M | Sell |
6,324
-1,750
| -22% | -$322K | ﹤0.01% | 1496 |
|
2016
Q3 | $2.08M | Buy |
8,074
+332
| +4% | +$85.5K | ﹤0.01% | 1362 |
|
2016
Q2 | $1.65M | Sell |
7,742
-1,076
| -12% | -$230K | ﹤0.01% | 1427 |
|
2016
Q1 | $1.82M | Buy |
8,818
+2,053
| +30% | +$423K | ﹤0.01% | 1405 |
|
2015
Q4 | $1.71M | Sell |
6,765
-3,757
| -36% | -$950K | ﹤0.01% | 1505 |
|
2015
Q3 | $1.73M | Buy |
10,522
+5,382
| +105% | +$885K | ﹤0.01% | 1504 |
|
2015
Q2 | $965K | Buy |
5,140
+660
| +15% | +$124K | ﹤0.01% | 1694 |
|
2015
Q1 | $739K | Buy |
4,480
+167
| +4% | +$27.5K | ﹤0.01% | 1763 |
|
2014
Q4 | $1M | Sell |
4,313
-11,795
| -73% | -$2.74M | ﹤0.01% | 1589 |
|
2014
Q3 | $2.92M | Sell |
16,108
-507
| -3% | -$91.8K | ﹤0.01% | 1176 |
|
2014
Q2 | $3.2M | Sell |
16,615
-513
| -3% | -$98.6K | ﹤0.01% | 1157 |
|
2014
Q1 | $3.11M | Sell |
17,128
-1,363
| -7% | -$248K | ﹤0.01% | 1164 |
|
2013
Q4 | $3.15M | Sell |
18,491
-16,549
| -47% | -$2.82M | ﹤0.01% | 1127 |
|
2013
Q3 | $5.49M | Sell |
35,040
-16,481
| -32% | -$2.58M | 0.01% | 962 |
|
2013
Q2 | $8.93M | Buy |
+51,521
| New | +$8.93M | 0.01% | 801 |
|